Cookies on Legislation.gov.uk

The cookies on legislation.gov.uk do two things: they remember any settings you've chosen so you don't have to choose them on every page, and they help us understand how people browse our website, so we can make improvements and fix problems. We need your consent to use some of these cookies.

The Misuse of Drugs (Designation) (Amendment No.2) (England, Wales and Scotland) Order 2012

Amendment to the Misuse of Drugs (Designation) Order 2001

This section has no associated Explanatory Memorandum

2.  In Part 1 of the Schedule to the Misuse of Drugs (Designation) Order 2001(1) after paragraph 1(r), insert—

“(s)Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,

(i)by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;

(ii)by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;

(iii)by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.”.

(1)

S.I. 2001/3997 as amended by S.I. 2005/1652, S.I. 2009/3135, S.I. 2010/1143, S.I. 2010/1800, S.I. 2011/447, and S.I. 2012/276 which was not published and was revoked by S.I. 2012/384.